Theravance Biopharma Inc’s recent filing unveils that its SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda unloaded Company’s shares for reported $0.11 million on Jul 14 ’25. In the deal valued at $11.39 per share,10,000 shares were sold. As a result of this transaction, Farnum Rhonda now holds 326,918 shares worth roughly $3.9 million.
Then, RHONDA FARNUM bought 10,000 shares, generating $113,869 in total proceeds.
Before that, Farnum Rhonda sold 24,000 shares. Theravance Biopharma Inc shares valued at $264,000 were divested by the SVP, COMM & MEDICAL AFFAIRS at a price of $11.00 per share. As a result of the transaction, Farnum Rhonda now holds 336,918 shares, worth roughly $4.02 million.
Leerink Partners downgraded its Theravance Biopharma Inc [TBPH] rating to a Market perform from a an Outperform in a research note published on August 06, 2024; the price target was decreased to $10 from $15. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. Evercore ISI also remained covering TBPH and has decreased its forecast on January 08, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. SVB Leerink started covering the stock on May 23, 2022. It rated TBPH as “an Outperform”.
Price Performance Review of TBPH
On Tuesday, Theravance Biopharma Inc [NASDAQ:TBPH] saw its stock jump 4.56% to $11.92. Over the last five days, the stock has gained 7.48%. Theravance Biopharma Inc shares have risen nearly 55.21% since the year began. Nevertheless, the stocks have risen 26.67% over the past one year. While a 52-week high of $11.88 was reached on 08/12/25, a 52-week low of $7.86 was recorded on 04/07/25.
Levels Of Support And Resistance For TBPH Stock
The 24-hour chart illustrates a support level at 11.56, which if violated will result in even more drops to 11.19. On the upside, there is a resistance level at 12.14. A further resistance level may holdings at 12.35.
How much short interest is there in Theravance Biopharma Inc?
A steep rise in short interest was recorded in Theravance Biopharma Inc stocks on 2025-07-31, dropping by 39232.0 shares to a total of 4.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 4.16 million shares. There was a decline of -0.95%, which implies that there is a negative sentiment for the stock.
